Myxoedema coma is a medical emergency with high mortality. In this study, clinical response and plasma variations of thyroid hormones were analysed in 7 patients, 6 presenting with myxoedema coma and one with myxoedema ileus. These patients were treated with intravenous or oral l-thyroxine (l-T4). 1000 μ l-T4 iv were administered in two patients. Within 3 h, plasma T4 and triiodothyronine (T3) reached a peak upper normal range, then diminished slowly during 5–9 days. The 5 remaining patients were treated with 500 μg l-T4 po on the first day, then 100 μg l-T4 daily by mouth. Plasma T4 and T3 increased slowly, remaining in hypothyroid range but clinical response (assessed on mental status, pulse rate and body temperature) occurred within 24–72 h. Cortisone therapy was used in 3 patients. Two patients died of myocardial infarction, or septicemia, one while receiving cortisone therapy and i.v. l-T4, another one treated only by oral l-T4. This study suggests: 1) oral absorption of l-T4 is variable, but clinical response occurs quickly even in myxoedema ileus; 2) the intravenous route involves high peaks of plasma T4 and T3; 3) peripheral conversion of T4 to T3 allows gradually T3 delivery to organ systems, even if only l-T4 is used and 4) initial and daily dosage determinations need further studies.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Ord WM (1879) Cases of myxoedema. Trans Clin Soc Lond 13:15
Verbov JL (1964) Modern treatment of myxoedema coma associated with hypothermia. Lancet I:194–197
Holvey DN, Goodner CJ, Nicoloff JT, Dowling JT (1964) Treatment of myxoedema coma with intravenous thyroxine. Arch Intern Med 113:89–96
Olbricht TH, Hoff HG, Reinwein D (1985) High-dose thyroxine treatment of severe hypothyroidism: response of free thyroid hormones. Acta Endocrinol 267:82–83
Nicoloff JT (1976) Myxoedema coma. Pharmacol Ther C 1:161–169
Read DG, Hays MT, Hershman JM (1970) Absorption of oral thyroxine in hypothyroid and normal man. J Clin Endocrinol Metab 30:798–799
Hylander B, Rosenqvist U (1985) Treatment of myxoedema coma-factors associated with fatal outcome. Acta Endocrinol 108:65–71
Fourrier A, Wattel F, Lefebvre J, Montois R, Scherpereel P, Mouton Y, Vasseur-Poulain R (1974) Le coma myxoedémateux (à propos de 4 cas). Lille Méd 19:255–262
Rosenbaum RL, Barzel US (1982) Levothyroxine replacement dose for primary hypothyroidism decreases with age. Ann Intern Med 96:53–55
Sawin CT, Herman T, Molitch ME, London MH, Kramer SM (1983) Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyroid patients. Am J Med 75:206–209
Cornu P, Bickert P, Segrestaa JM, Marsan C, Ertel M, Manicacci M, Laffay J, Lamotte M (1973) Le coma myxoedémateux. Etude de 3 cas. Sem Hôp Paris 49:1449–1458
Desjars Ph, De Rostu H, Charbonnel B (1983) Le coma myxoedémateux. A propos de 8 observations. Rev Méd Interne 4:271–277
Khaleeli AA (1978) Myxoedema coma. A report on five successfully treated cases. Postgrad Med J 54:825–829
Yamauchi K, Takasu N, Ichikawa K, Yamada T, Aizawa T (1984) Effects of long-term treatment with thyroxine on pituitary TSH secretion and heart action in patients with hypothyroidism. Acta Endocrinol 107:218–224
Ridgway EC, McCammon JA, Benotti J, Maloof F (1972) Acute metabolic responses in myxoedema to large doses of intravenous l-thyroxine. Ann Intern Med 77:549–555
About this article
Cite this article
Arlot, S., Debussche, X., Lalau, J.D. et al. Myxoedema coma: Response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment. Intensive Care Med 17, 16–18 (1991). https://doi.org/10.1007/BF01708403
- Myxoedema coma
- Myxoedema ileus